Marisa Passarelli

2.5k total citations
105 papers, 1.8k citations indexed

About

Marisa Passarelli is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Surgery. According to data from OpenAlex, Marisa Passarelli has authored 105 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Clinical Biochemistry and 32 papers in Surgery. Recurrent topics in Marisa Passarelli's work include Advanced Glycation End Products research (33 papers), Cholesterol and Lipid Metabolism (25 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Marisa Passarelli is often cited by papers focused on Advanced Glycation End Products research (33 papers), Cholesterol and Lipid Metabolism (25 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers). Marisa Passarelli collaborates with scholars based in Brazil, United States and United Kingdom. Marisa Passarelli's co-authors include E.R. Nakandakare, E.C.R. Quintão, Ubiratan Fabres Machado, Sérgio Catanozi, Maria Lúcia Corrêa‐Giannella, Raphael de Souza Pinto, Rodrigo Tallada Iborra, Adriana Machado‐Lima, V.S. Nunes and Gabriela Castilho and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Marisa Passarelli

101 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marisa Passarelli 697 483 469 402 341 105 1.8k
Sally A. Penfold 669 1.0× 282 0.6× 590 1.3× 794 2.0× 353 1.0× 24 1.9k
Jay C. Jha 453 0.6× 229 0.5× 902 1.9× 512 1.3× 519 1.5× 38 2.5k
Gloria Formoso 631 0.9× 297 0.6× 661 1.4× 142 0.4× 384 1.1× 59 2.2k
Aino Soro‐Paavonen 1.0k 1.4× 450 0.9× 602 1.3× 551 1.4× 402 1.2× 30 2.5k
Domenico De Cesare 377 0.5× 282 0.6× 332 0.7× 376 0.9× 173 0.5× 22 1.9k
Theodor Koschinsky 884 1.3× 318 0.7× 242 0.5× 699 1.7× 302 0.9× 36 1.7k
Tadashi Suehiro 519 0.7× 510 1.1× 491 1.0× 945 2.4× 228 0.7× 92 2.5k
Daisuke Kukidome 364 0.5× 353 0.7× 1.1k 2.3× 287 0.7× 570 1.7× 30 2.2k
Josep Julve 784 1.1× 1.0k 2.2× 743 1.6× 143 0.4× 331 1.0× 133 2.4k
Kenya Sakamoto 609 0.9× 301 0.6× 390 0.8× 382 1.0× 200 0.6× 41 1.8k

Countries citing papers authored by Marisa Passarelli

Since Specialization
Citations

This map shows the geographic impact of Marisa Passarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Passarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Passarelli more than expected).

Fields of papers citing papers by Marisa Passarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Passarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Passarelli. The network helps show where Marisa Passarelli may publish in the future.

Co-authorship network of co-authors of Marisa Passarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Passarelli. A scholar is included among the top collaborators of Marisa Passarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Passarelli. Marisa Passarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Félix, V., et al.. (2024). The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis. International Journal of Molecular Sciences. 25(20). 10980–10980. 2 indexed citations
2.
Corrêa‐Giannella, Maria Lúcia, et al.. (2024). Proteomic Profiling of HDL in Newly Diagnosed Breast Cancer Based on Tumor Molecular Classification and Clinical Stage of Disease. Cells. 13(16). 1327–1327. 4 indexed citations
3.
Passarelli, Marisa, et al.. (2024). Unraveling the Pleiotropic Role of High‐Density Lipoproteins (HDLs) in Autoimmune Rheumatic Diseases. International Journal of Rheumatology. 2024(1). 1896817–1896817.
4.
Furukawa, Luzia Naôko Shinohara, M. Okamoto, Aritânia Sousa Santos, et al.. (2024). Aerobic Exercise Training Protects Against Insulin Resistance, Despite Low-Sodium Diet-Induced Increased Inflammation and Visceral Adiposity. International Journal of Molecular Sciences. 25(18). 10179–10179. 4 indexed citations
5.
Toyoshima, Marcos Tadashi Kakitani, Adriana Bosco, Bruno Caramelli, et al.. (2023). Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology & Metabolic Syndrome. 15(1). 42–42. 5 indexed citations
6.
Santos, Aritânia Sousa, Maria Lúcia Corrêa‐Giannella, Luíz Henrique Gebrim, et al.. (2023). Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer. International Journal of Molecular Sciences. 24(16). 12762–12762. 4 indexed citations
7.
Iborra, Rodrigo Tallada, et al.. (2023). The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. Frontiers in Oncology. 13. 1111094–1111094. 6 indexed citations
8.
Yonamine, Caio Yogi, Marisa Passarelli, Cláudia Kimie Suemoto, et al.. (2023). Postmortem Brains from Subjects with Diabetes Mellitus Display Reduced GLUT4 Expression and Soma Area in Hippocampal Neurons: Potential Involvement of Inflammation. Cells. 12(9). 1250–1250. 9 indexed citations
9.
Nunes, V.S., et al.. (2023). Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors. Scientific Reports. 13(1). 8998–8998. 6 indexed citations
10.
Iborra, Rodrigo Tallada, et al.. (2023). The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer. Atherosclerosis. 379. S57–S58. 2 indexed citations
11.
Pinto, Raphael de Souza, et al.. (2022). Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques. Diabetes and Vascular Disease Research. 19(2). 1486927957–1486927957. 14 indexed citations
12.
Pinto, Raphael de Souza, et al.. (2022). Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. International Journal of Molecular Sciences. 23(5). 2404–2404. 32 indexed citations
13.
Machado‐Lima, Adriana, Rodrigo Tallada Iborra, Raphael de Souza Pinto, et al.. (2021). Persistent Effect of Advanced Glycated Albumin Driving Inflammation and Disturbances in Cholesterol Efflux in Macrophages. Nutrients. 13(10). 3633–3633. 11 indexed citations
14.
15.
16.
Machado‐Lima, Adriana, Raquel López‐Díez, Rodrigo Tallada Iborra, et al.. (2020). RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin. International Journal of Molecular Sciences. 21(19). 7265–7265. 15 indexed citations
17.
Santos, Aritânia Sousa, Cláudia Kimie Suemoto, Carlos Augusto Pasqualucci, et al.. (2020). Alcohol Use Disorder is Associated with Upregulation of MicroRNA‐34a and MicroRNA‐34c in Hippocampal Postmortem Tissue. Alcoholism Clinical and Experimental Research. 45(1). 64–68. 15 indexed citations
18.
19.
Souza, Francis Ribeiro de, Marcelo Rodrigues dos Santos, Guilherme Wesley Peixoto da Fonseca, et al.. (2019). Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis. 283. 100–105. 22 indexed citations
20.
Yonamine, Caio Yogi, João Victor Del Conti Esteves, Karina Thieme, et al.. (2018). Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression. Scientific Reports. 8(1). 8109–8109. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally A. Penfold Breakdown of academic impact, for papers by Jay C. Jha Breakdown of academic impact, for papers by Gloria Formoso Breakdown of academic impact, for papers by Aino Soro‐Paavonen Breakdown of academic impact, for papers by Domenico De Cesare Breakdown of academic impact, for papers by Theodor Koschinsky Breakdown of academic impact, for papers by Tadashi Suehiro Breakdown of academic impact, for papers by Daisuke Kukidome Breakdown of academic impact, for papers by Josep Julve Breakdown of academic impact, for papers by Kenya Sakamoto
Rankless by CCL
2026